Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569,...

Clinical Cancer Research 2008 / 01 Vol. 14; Iss. 1

Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer

Folprecht, G., Tabernero, J., Kohne, C.-H., Zacharchuk, C., Paz-Ares, L., Rojo, F., Quinn, S., Casado, E., Salazar, R., Abbas, R., Lejeune, C., Marimon, I., Andreu, J., Ubbelohde, U., Cortes-Funes, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-07-1053
Date:
January, 2008
File:
PDF, 345 KB
english, 2008
Conversion to is in progress
Conversion to is failed